Resultados de búsqueda - Karla V. Ballman
- Mostrando 1 - 20 Resultados de 111
- Ir a la Siguiente Página
-
1
Biomarker: Predictive or Prognostic? por Karla V. Ballman
Publicado 2015Revisão -
2
Precision Oncology: An Overview por Levi A. Garraway, Jaap Verweij, Karla V. Ballman
Publicado 2013Artigo -
3
-
4
-
5
-
6
-
7
Survival Implications of Variation in the Thoroughness of Pathologic Lymph Node Examination in American College of Surgeons Oncology Group Z0030 (Alliance) por Raymond U. Osarogiagbon, Paul A. Decker, Karla V. Ballman, Dennis A. Wigle, Mark S. Allen, Gail Darling
Publicado 2016Artigo -
8
-
9
-
10
Effect of body mass index on tumor characteristics and disease‐free survival in patients from the HER2‐positive adjuvant trastuzumab trial N9831 por Jennifer A. Crozier, Alvaro Moreno‐Aspitia, Karla V. Ballman, Amylou C. Dueck, Barbara A. Pockaj, Edith A. Perez
Publicado 2013Artigo -
11
-
12
Validation of neuroradiologic response assessment in gliomas: Measurement by RECIST, two-dimensional, computer-assisted tumor area, and computer-assisted tumor volume methods1 por Evanthia Galanis, Jan C. Buckner, Matthew J. Maurer, Rene Sykora, René Castillo, Karla V. Ballman, Bradley J. Erickson
Publicado 2006Artigo -
13
-
14
Impact of Radiation on Locoregional Control in Women with Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy and Axillary Lymph Node Dissection: Results from ACOSOG... por Bruce G. Haffty, Linda McCall, Karla V. Ballman, Thomas A. Buchholz, Kelly K. Hunt, Judy C. Boughey
Publicado 2019Artigo -
15
Association of Stromal Tumor-Infiltrating Lymphocytes With Recurrence-Free Survival in the N9831 Adjuvant Trial in Patients With Early-Stage HER2-Positive Breast Cancer por Edith A. Perez, Karla V. Ballman, Kathy S. Tenner, E. Aubrey Thompson, Sunil Badve, Helen D. Bailey, Frederick L. Baehner
Publicado 2015Artigo -
16
-
17
Association Studies of Fcγ Receptor Polymorphisms with Outcome in HER2+ Breast Cancer Patients Treated with Trastuzumab in NCCTG (Alliance) Trial N9831 por Nadine Norton, Rebecca M. Olson, Mark D. Pegram, Kathleen Tenner, Karla V. Ballman, Raphael Clynes, Keith L. Knutson, Edith A. Perez
Publicado 2014Artigo -
18
-
19
-
20
Impact of race, ethnicity, and BMI on achievement of pathologic complete response following neoadjuvant chemotherapy for breast cancer: a pooled analysis of four prospective Allian... por Erica T. Warner, Karla V. Ballman, Carrie Strand, Judy C. Boughey, Aman U. Buzdar, Lisa A. Carey, William M. Sikov, Ann H. Partridge
Publicado 2016Artigo
Herramientas de búsqueda:
Materias Relacionadas
Medicine
Internal medicine
Cancer
Oncology
Surgery
Breast cancer
Biology
Cancer research
Chemotherapy
Pathology
Gene
Genetics
Clinical trial
Randomized controlled trial
Confidence interval
Radiation therapy
Lymph node
Radiology
Sentinel lymph node
Biochemistry
Clinical endpoint
Glioblastoma
Cardiology
Cohort
Glioma
Hazard ratio
Metastasis
Prostate cancer
Disease
Population